Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19.
Reinshagen L, Nageswaran V, Heidecke H, Schulze-Forster K, Wilde AB, Ramezani Rad P, Poller W, Asmus E, Simmons S, Kuebler WM, Witzenrath M, Markó L, Jakobs K, Puccini M, Leistner DM, Rauch-Kröhnert U, Kränkel N, Forslund SK, Landmesser U, Müller DN, Haghikia A. Reinshagen L, et al. Among authors: puccini m. Thromb Haemost. 2023 Dec 29. doi: 10.1055/a-2205-0014. Online ahead of print. Thromb Haemost. 2023. PMID: 37931906 No abstract available.
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
Rauch-Kröhnert U, Puccini M, Placzek M, Beyer-Westendorf J, Jakobs K, Friebel J, Hein S, Seidel M, Pieske B, Massberg S, Witzenrath M, Zeiher A, Friede T, Anker SD, Landmesser U. Rauch-Kröhnert U, et al. Among authors: puccini m. Clin Res Cardiol. 2023 Nov;112(11):1620-1638. doi: 10.1007/s00392-023-02240-1. Epub 2023 Jul 5. Clin Res Cardiol. 2023. PMID: 37407731 Free PMC article. Clinical Trial.
Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19.
Puccini M, Jakobs K, Reinshagen L, Friebel J, Schencke PA, Ghanbari E, Landmesser U, Haghikia A, Kränkel N, Rauch U. Puccini M, et al. Int J Mol Sci. 2023 Apr 22;24(9):7683. doi: 10.3390/ijms24097683. Int J Mol Sci. 2023. PMID: 37175392 Free PMC article.
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.
Friebel J, Moritz E, Witkowski M, Jakobs K, Strässler E, Dörner A, Steffens D, Puccini M, Lammel S, Glauben R, Nowak F, Kränkel N, Haghikia A, Moos V, Schutheiss HP, Felix SB, Landmesser U, Rauch BH, Rauch U. Friebel J, et al. Among authors: puccini m. Cells. 2021 Dec 13;10(12):3517. doi: 10.3390/cells10123517. Cells. 2021. PMID: 34944024 Free PMC article.
11 results